comparemela.com
Latest Breaking News On - Neuro oncology group - Page 1 : comparemela.com
Dr Hansford on the FIREFLY-1 Trial of Tovorafenib in Pediatric Low-Grade Glioma
Jordan Hansford, MD, discusses the phase 2 FIREFLY-1 trial, which is investigating the pan-RAF inhibitor tovorafenib (DAY101) in children and young adults with low-grade glioma.
Melbourne
Victoria
Australia
Oncology-group
Oncology-research-conference
Jordan-hansford
Neuro-oncology-group
Royal-children
Hospital-melbourne
Neuro-oncology-research-conference
Response-assessment
vimarsana © 2020. All Rights Reserved.